XML 80 R27.htm IDEA: XBRL DOCUMENT v3.26.1
Segment Information (Tables)
12 Months Ended
Dec. 31, 2025
Segment Information [Abstract]  
Schedule of Significant Segment Expenses

The following table summarized significant segment expenses for the years ended December 31, 2025 and 2024:

 

   Lysosomal Storage
Disorders Segment
 
   Year Ended December 31, 
   2025   2024 
   (In thousands) 
Research and development expenses (excluding stock compensation) $(1,922) $(1,077)
General and administrative expenses (excluding stock compensation)  (1,174)  (875)
Stock-based compensation  (4,725)  (2,400)
Recapitalization of common stock     (26,004)
Other expense – direct listing offering costs  (1,164)   
Net loss $(8,985) $(30,356)